| タイトル |
-
Direction for Basal Insulin Therapy by Once Daily Injection in the Clinical Practice
|
| 作成者 |
|
| 権利情報 |
-
This is an open-access article distributed under the Creative Commons Attribution License(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
|
| 主題 |
-
Other
American Diabetes Association (ADA)
-
Other
Dual Action of Liraglutide and Insulin Degludec (DUAL) studies
-
Other
Xultophy
-
Other
Multiple Daily Injection (MDI)
-
Other
Once Daily Injection
|
| 内容注記 |
-
Other
American Diabetes Association (ADA) has announced the new version of the standards of Medical Care in Diabetes-2021. The guideline of the diabetic patients with Older Adults seems to be used for a wide range of clinical practice. Among them, several impressive comments were found, where “Once-daily basal insulin injection therapy is associated with minimal side effects and maybe a reasonable option in many elder patients”. Recent topic includes Dual Action of Liraglutide and insulin degludec (DUAL) studies, and Xultophy has shown beneficial efficacy. Consequently, the trend would be developed from multiple daily injection (MDI) method to once daily injection.
|
| 出版者 |
Asploro
|
| 日付 |
|
| 言語 |
|
| 資源タイプ |
journal article |
| 出版タイプ |
VoR |
| 資源識別子 |
URI
http://repo.lib.tokushima-u.ac.jp/115863
|
| 関連 |
-
isIdenticalTo
DOI
https://doi.org/10.36502/2021/droa.6177
|
| 収録誌情報 |
-
Diabetes Research : Open Access
-
巻3
号1
開始ページ11
終了ページ15
|
| ファイル |
|
| コンテンツ更新日時 |
2023-06-26 |
